|
Market Closed -
Nasdaq
01:27:30 15/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 213.38 USD | -0.14% |
|
+0.30% | +16.83% |
| 12/08 | UBS Adjusts Price Target on Axsome Therapeutics to $280 From $259, Keeps Buy Rating | MT |
| 12/08 | Mizuho Adjusts PT on Axsome Therapeutics to $316 From $306, Keeps Outperform Rating | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
AXSM 213.38 $
-0.14%
10Cr
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| AXSM | 213.38USD | -0.14% | 10Cr $ | |
CBOE
| AXSM | 213.60USD | -0.04% | 63.64L $ | |
Boerse Muenchen
| 19X | 184.95EUR | 0.00% | 17.2T € | |
Xetra
| 19X | 185.35EUR | -2.47% | 4.82T € | |
Tradegate
| 19X | 184.80EUR | -0.27% | 184.8 € | |
Deutsche Boerse AG
| 19X | 183.50EUR | -0.57% | 0 € | |
Börse Stuttgart
| 19X | 184.15EUR | -0.75% | 0 € | |
Borsa Italiana
| 1AXSM | 185.25EUR | -2.53% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Bullish |
| Resistance | 228.28 | 255.17 | 255.17 |
| Spread/Res. | -6.53% | -16.38% | -16.38% |
| Spread/Supp. | +1.54% | +12.90% | +25.97% |
| Support | 210.13 | 188.99 | 169.38 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AXSM Stock
- Charts Axsome Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions

















